Heffernan Michael Thomas Insider Trades

Insider Trading History

Track insider trading activity for Heffernan Michael Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
enGene Holdings
enGene Holdings ENGN
Director
Holding Value $53k 31,000 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.3k 31,000 shares
$1.75
$1.71
enGene Holdings- Warrants (31/10/2028)
enGene Holdings- Warrants (31/10/2028) ENGNW
Director
Holding Value $8.67k 31,000 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.22k 31,000 shares
$0.26
$0.28
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $608k 35,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 35,000 shares
$13.45
$17.38
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $526k 29,500 shares
Last Trade
Jun 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 29,500 shares
$13.96
$17.83
Biohaven
Biohaven BHVN
Director
Holding Value $1.02M 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$14.78
enGene Holdings- Warrants (31/10/2028)
enGene Holdings- Warrants (31/10/2028) ENGNW
Director
Holding Value $12.6k 45,000 shares
Last Trade
Jul 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41k 45,000 shares
$0.91
$0.28
enGene Holdings
enGene Holdings ENGN
Director
Holding Value $77k 45,000 shares
Last Trade
Jul 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 45,000 shares
$3.83
$1.71
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $526k 29,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 29,500 shares
$4.47
$17.83
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $782k 45,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$281k 45,000 shares
$6.25
$17.38
Biohaven
Biohaven BHVN
Director
Holding Value $469k 31,716 shares
Last Trade
May 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$717k 31,716 shares
$22.62
$14.78
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $892k 50,000 shares
Last Trade
Mar 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 50,000 shares
$8.54
$17.83
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.74M 50,328 shares
Last Trade
Feb 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 4,820 shares
$30.52
$34.62
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $521k 30,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.1k 30,000 shares
$2.77
$17.38
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.58M 45,508 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 7,693 shares
$33.67
$34.62
Biohaven
Biohaven BHVN
Director
Holding Value $245k 16,592 shares
Last Trade
Apr 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$644k 16,592 shares
$38.80
$14.78
Trevi Therapeutics
Trevi Therapeutics TRVI
Director
Holding Value $521k 30,000 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.1k 30,000 shares
$2.27
$17.38
Synlogic
Synlogic SYBX
Director
Holding Value $21k 30,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$227k 30,000 shares
$7.57
$0.70
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.31M 37,815 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 9,792 shares
$22.53
$34.62
Biohaven
Biohaven BHVN
Director
Holding Value $782k 52,906 shares
Last Trade
May 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$698k 52,906 shares
$13.20
$14.78
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.52M 44,018 shares
Last Trade
Dec 27, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$467k 19,815 shares
$23.55
$34.62

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up